News | Coronavirus (COVID-19) | November 09, 2021

Vascular Disease in COVID-19 is Not Caused by Viral Infection of Blood Vessels

SARS-CoV-2 does not infect blood vessels, despite the high risk of blood clots to COVID-19 patients

SARS-CoV-2 (COVID-19) virus added to cells. Image from the Institute for Molecular Bioscience, The University of Queensland. Image of the COVID-19 Virus

SARS-CoV-2 virus added to cells. Image from the Institute for Molecular Bioscience, The University of Queensland


November 9, 2021 — The COVID-19 (SARS-CoV-2) virus does not infect blood vessels, despite the high risk of blood clots to COVID-19 patients, researchers recently found at University of Queensland in Australia.

Dr. Emma Gordon and Dr. Larisa Labzin from UQ’s Institute for Molecular Bioscience and Dr. Kirsty Short from UQ’s School of Chemistry and Molecular Biosciences pooled their expertise in vascular biology and virology to determine how the virus causes damage to blood vessels.

The researchers found that the cardiovascular complications of COVID-19 are triggered by inflammation caused by infected airway cells.

“At least 40 per cent of patients that are hospitalized with COVID-19 are at high risk of blood clots, and anti-coagulation therapies are now being routinely used,” Dr Gordon said.

“There have been many studies attempting to prove whether the virus is infecting cells of the inner blood vessel wall or not.

“By conducting our experiments using real, infectious virus rather than fragments of the virus’s spike protein, we can definitively say it is not.”

The researchers used UQ’s sophisticated microscopy facilities to track where the virus traveled in the cells and visualize how blood vessels respond to the live virus.

Immunologist Labzin said the body’s inflammatory response had a big effect on the cardiovascular system because they work together to fight infection – the blood delivers the immune cells to the site of infection and makes blood clots if the blood vessel is damaged.

“When our immune system works well, it clears the virus from our bodies,” Labzin said.

“But sometimes it goes into overdrive and we get an overblown inflammatory response causing complications –in the case of COVID-19, this is often blood clots, when there shouldn’t be any.
“Knowing that it is inflammation causing these cardiovascular complications arising from COVID-19 rather than the virus itself will help us develop the right treatments, and a better understanding of how and why these complications arise.”

Heart Foundation interim CEO, Professor Garry Jennings said the study helps clarify a key debate about the relationship between the virus and the lining of the blood vessels.

“How the cells lining the blood vessels sense the virus and the damage to nearby cells is still not completely understood,” he said.

“There is more research to do, but this study is an important step in our understanding of the virus and which cells and mechanisms we should look at next.”

This research is published in Clinical and translational Immunology .[1]

This work was supported by a Future Leader Fellowship (104692) from the National Heart Foundation of Australia and the National Health and Medical Research Council.

Find out more details in a video created by the University of Queensland researchers.

Find more cardiology related COVID news

 

Reference:

1. Lilian Schimmel, Keng Yih Chew, Claudia J Stocks, et al. Endothelial cells are not productively infected by SARS-CoV-2. Clinical and translational Immunology. First published 24 October 2021 https://doi.org/10.1002/cti2.1350.
 

Related Content

News | Coronavirus (COVID-19)

December 1, 2021 — A small but significant percentage of college athletes with COVID-19 develop myocarditis, a ...

Home December 01, 2021
Home
News | Coronavirus (COVID-19)

November 23, 2021 — The antiplatelet drug class of P2Y12 inhibitors that block the activity of platelets and prevents ...

Home November 23, 2021
Home
News | Coronavirus (COVID-19)

November 19, 2021 — A high dose of a purified omega-3 fatty acid, available by prescription only, was well tolerated ...

Home November 19, 2021
Home
News | Coronavirus (COVID-19)

November 17, 2021 — People in the U.S. who live in socially vulnerable neighborhoods, which includes communities with ...

Home November 17, 2021
Home
News | Coronavirus (COVID-19)

November 5, 2021 — In the worldwide effort to battle COVID-19 (SARS-CoV-2), researchers have often turned to medications ...

Home November 05, 2021
Home
Feature | Coronavirus (COVID-19)

November 5, 2021 — The U.S. Food and Drug Administration (FDA) authorized the emergency use of the Pfizer-BioNTech COVID ...

Home November 05, 2021
Home
Feature | Coronavirus (COVID-19) | By Dave Fornell, DAIC Editor

November 4, 2021 — The Centers for Medicare and Medicaid Services (CMS) today issued an emergency regulation now ...

Home November 04, 2021
Home
News | Coronavirus (COVID-19)

October 15, 2021 — The correlation between poor oral health and COVID-19 (SARS-CoV-2) severity, as well as the ...

Home October 15, 2021
Home
News | Coronavirus (COVID-19)

September 28, 2021 — A research team at the University of Arkansas for Medical Sciences (UAMS) has identified a ...

Home September 28, 2021
Home
News | Coronavirus (COVID-19)

August 23, 2021 — The U.S. Food and Drug Administration (FDA) just granted full approval to the Pfizer/BioNTech COVID-19 ...

Home August 23, 2021
Home
Subscribe Now